treating ACUTE COVID-19, COPD and Asthma
At the core of Inspiritol are compounds that serve to reestablish the anti-oxidant oxidant balance in the lungs while reducing or eliminating inflammation associated with most acute respiratory distress. .
Breaking the Long COVID and ME/CFS cycle of immune dysregulation with Inspiritol
Long-COVID and ME/CFS (Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome) result from aberrant responses to immunological triggers like an infection which results in a permanently dysregulated immune system as a result of over activation of certain T-Cells, their subsequent exhaustion and metabolic disruption .
Dr. Salerno Collaboration with Dr. Liisa Selin
Recently, under an NIH funded research grant, Dr. Liisa Selin of UMass Chan Medical School, discovered similar immune system dysregulated responses in both Long-COVID and ME/CFS patients. These include CD-8 T cell exhaustion, type II interferon exhaustion and evidence of difficulty controlling persistent viral pathogens.
With the same biomarker analyses, they reported the treatment of Long-COVID and ME/CFS patients using Inspiritol resulted in modulation of their immune system response towards a more normal profile in addition to sustained symptomatic relief.